2004•Academic Journal of Second Military Medical UniversityRequires access

Effects of hVEGF_(121 ) gene transfection on human umbilical vein endothelial cells growth

Hong Li

Open publisher page 0 citations

Abstract

Objective:To construct human vascular endothelial growth factor (hVEGF)-121 protein expression plasmid, and to transfect it into human umbilical vein endothelial cells (HUVEC) to speed up their growth in vitro through a paracrine way. Methods: hVEGF 121 cDNA was obtained by reverse transcription-polymerase chain reaction (RT-PCR) from human embryonic fibroblast and was inserted into eukaryotic expression vector pcDNA3. The recombinant plasmid was tranfected into HUVEC by FuGENE 6 liposome. The culture supernatant of the transfected cells was collected, and the expression of hVEGF protein was tested by enzyme-linked immunosorbent assay (ELISA). The role of hVEGF 121 gene transfer in HUVEC proliferation was studied by cell-counting. pcDNA3 vector transfected and non-transfected HUVEC were used as the control groups. Results: pcDNA3-hVEGF 121 plasmid was constructed. After cell transfection, hVEGF protein was transiently expressed and peaked on 1 d at 59.95 pg/(10 4 cells·d), about 100 times that of the control group level; afterwards, the productions decreased quickly and then slowly, but still about 1 time higher than that of the control group level on 7 d. The transfected HUVEC proliferated more rapidly than that of the control groups on 3 d (P0.01),with the cell doubling time shortened to about 3 d from over 7 d in the control group.Conclusion:Plasmid pcDNA3- hVEGF 121 has been constructed successfully, which can express active hVEGF 121 protein in HUVEC cultured in vitro,thus promoting HUVEC proliferation by a paracrine loop.

About this research paper

What this paper is about

Objective:To construct human vascular endothelial growth factor (hVEGF)-121 protein expression plasmid, and to transfect it into human umbilical vein endothelial cells (HUVEC) to speed up their growth in vitro through a paracrine way. Methods: hVEGF 121 cDNA was obtained by reverse transcription-polymerase chain reaction (RT-PCR) from human embryonic fibroblast and was inserted into eukaryotic expression vector pcDNA3. The recombinant plasmid was tranfected into HUVEC by FuGENE 6 liposome. The culture supernatant of the transfected cells was collected, and the expression of hVEGF protein was tested by enzyme-linked immunosorbent assay (ELISA). The role of hVEGF 121 gene transfer in HUVEC proliferation was studied by cell-counting. pcDNA3 vector transfected and non-transfected HUVEC were used as the control groups. Results: pcDNA3-hVEGF 121 plasmid was constructed. After cell transfection, hVEGF protein was transiently expressed and peaked on 1 d at 59.95 pg/(10 4 cells·d), about 100 times that of the control group level; afterwards, the productions decreased quickly and then slowly, but still about 1 time higher than that of the control group level on 7 d. The transfected HUVEC proliferated more rapidly than that of the control groups on 3 d (P0.01),with the cell doubling time shortened to about 3 d from over 7 d in the control group.Conclusion:Plasmid pcDNA3- hVEGF 121 has been constructed successfully, which can express active hVEGF 121 protein in HUVEC cultured in vitro,thus promoting HUVEC proliferation by a paracrine loop.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To construct human vascular endothelial growth factor (hVEGF)-121 protein expression plasmid, and to transfect it into human umbilical vein endothelial cells (HUVEC) to speed up their growth in vitro through a paracrine way. Methods: hVEGF 121 cDNA was obtained by reverse transcription-polymerase chain reaction (RT-PCR) from human embryonic fibroblast and was inserted into eukaryotic expression vector pcDNA3. The recombinant plasmid was tranfected into HUVEC by FuGENE 6 liposome. The culture supernatant of the transfected cells was collected, and the expression of hVEGF protein was tested by enzyme-linked immunosorbent assay (ELISA). The role of hVEGF 121 gene transfer in HUVEC proliferation was studied by cell-counting. pcDNA3 vector transfected and non-transfected HUVEC were used as the control groups. Results: pcDNA3-hVEGF 121 plasmid was constructed. After cell transfection, hVEGF protein was transiently expressed and peaked on 1 d at 59.95 pg/(10 4 cells·d), about 100 times that of the control group level; afterwards, the productions decreased quickly and then slowly, but still about 1 time higher than that of the control group level on 7 d. The transfected HUVEC proliferated more rapidly than that of the control groups on 3 d (P0.01),with the cell doubling time shortened to about 3 d from over 7 d in the control group.Conclusion:Plasmid pcDNA3- hVEGF 121 has been constructed successfully, which can express active hVEGF 121 protein in HUVEC cultured in vitro,thus promoting HUVEC proliferation by a paracrine loop.

Key concepts: Transfection, Umbilical vein, Molecular biology, Paracrine signalling, Genetic enhancement, Complementary DNA, Biology, Cell culture

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of hVEGF_(121 ) gene transfection on human umbilical vein endothelial cells growth — Research Paper | ScholarLens